Publication:
Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies.

Simple item page
dc.contributor.authorFreites-Martinez, A
dc.contributor.authorSantana, N
dc.contributor.authorArias-Santiago, S
dc.contributor.authorViera, A
dc.date.accessioned2023-02-09T09:40:02Z
dc.date.available2023-02-09T09:40:02Z
dc.date.issued2020-09-03
dc.identifier.doi10.1016/j.ad.2019.05.009
dc.identifier.essn2173-5778
dc.identifier.pmid32891586
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.ad.2019.05.009
dc.identifier.urihttp://hdl.handle.net/10668/16214
dc.issue.number1
dc.journal.titleActas dermo-sifiliograficas
dc.journal.titleabbreviationActas Dermosifiliogr (Engl Ed)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number90-92
dc.pubmedtypeCase Reports
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAdverse Drug Reaction Reporting Systems
dc.subject.meshNational Cancer Institute (U.S.)
dc.subject.meshUnited States
dc.titleUsing the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies.
dc.title.alternativeCTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number112
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía